Sandmann S, Unger T L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201 PDF Summary Overview
| ||||||||||||||||
Figure/Graphic 2: L-Typ-Kalziumkanal - Medikamenteninteraktion Schematic overview of the drug interaction sites of the CCA (dihydropyridines, diltiazem, verapamil, fantofarone, mibefradil) with the L-type calcium channel |
![]()
Figure/Graphic 2: L-Typ-Kalziumkanal - Medikamenteninteraktion
Schematic overview of the drug interaction sites of the CCA (dihydropyridines, diltiazem, verapamil, fantofarone, mibefradil) with the L-type calcium channel |